PubMed Health⌕ Search

PubMed · 4059506

Duodenitis: a clinical, endoscopic and histopathologic study.

Abstract

In 219 subjects who presented with dyspepsia the findings of serial endoscopies and mucosal biopsies ranged over periods from three to 12 months (48.9 per cent) and three to 36 months (51.1 per cent) were studied. The minimum number of endoscopies per subject was four. One hundred and sixty-three subjects had one or more periods of treatment with cimetidine. One hundred and thirty-five had a pentagastrin-stimulated maximal acid output measurement. At the initial endoscopy 78 subjects had either non-erosive or erosive duodenitis but no ulcer: 48 per cent of these ultimately developed an ulcer. By the final endoscopy three to 36 months after the initial one, 81.8 per cent of the 219 had shown an ulcer crater at one or more endoscopy examinations. Erosive duodenitis on 276 occasions, was more common than non-erosive duodenitis on 187 occasions. Erosive duodenitis is significantly associated with a raised acid secretory capacity. Serial endoscopies reveal a permutation of association between the different degrees of duodenitis and the presence of one or more ulcer crater. The commonest permutations are non-erosive duodenitis or erosive duodenitis or ulcer (30.1 per cent) and erosive duodenitis or ulcer (23.7 per cent). Ulcer without duodenitis at any time was only seen in 8.2 per cent and duodenitis without an ulcer at any time in 18.3 per cent. Treatment with cimetidine resulted in healing of ulcer craters in 68.5 per cent but resolution of the duodenitis was observed in only 28.1 per cent.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W Sircus. 1985. Duodenitis: a clinical, endoscopic and histopathologic study.. https://pubmed.ncbi.nlm.nih.gov/4059506/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Prediction of the glomerular filtration rate using equations in kidney-pancreas transplant patients receiving cimetidine.

BACKGROUND: Current estimates of renal function in kidney transplant patients are frequently inaccurate compared to radionuclide GFR (rGFR) measurement. Cimetidine inhibits tubular secretion of creatinine and improves the accuracy of formulas to estimate GFR. METHODS: We studied the effect of a cimetidine-aided (800 mg tid for 24 hr) serum creatinine on the correlation of creatinine clearance and three prediction formulas (Cockroft-Gault, Levey, and Nankivell) compared to rGFR in 15 kidney-pancreas transplant patients. Results were adjusted for body surface area. RESULTS: Correlations with rGFR using cimetidine-aided creatinine were: Cockroft-Gault, r=0.710; Levey, r=0.752; Nankivell, r=0.676; creatinine clearance, r=0.643. By Bland and Altman analysis, agreement with rGFR was best with the Nankivell and Cockroft-Gault equations and worst with creatinine clearance. Cimetidine ($0.48 Canadian) costs substantially less than the rGFR test ($66.00 Canadian). CONCLUSION: Using cimetidine, prediction equations give a stronger correlation with GFR than creatinine clearance.

Cimetidine↗

In vitro availability of metformin in presence of h(2) receptor antagonists.

Metformin is a guanidine derivative used for the treatment of NIDDM. As it is used for a long-term therapy, it may be coadministered with other drugs. Present paper deals with the in vitro availability studies of metformin in presence of commonly used H(2) receptor antagonists. The later drugs compete with histamine for H(2) receptors and block gastric acid secretion and some cardiovascular effects of histamine. These studies were carried out in simulated gastric juices, simulating empty and full stomach, simulated intestinal juice and buffers of pH 7.4 simulating blood pH at 37 degrees C on a B.P. 2003 dissolution test apparatus. Commonly prescribed H(2) receptor antagonists like cimetidine, ranitidine and famotidine were used in these studies. The present study clearly indicated that availability of metformin can be altered in presence of most of the H(2) receptor antagonists studied except in presence of famotidine at pH 4 where the drug concentration remains unaltered. The availability of metformin was increased in simulated gastric juice, pH 7.4 and pH 9 (except ranitidine at pH 9) whereas the decrease in availability was observed in presence of cimetidine and ranitidine at pH 4 and ranitidine at pH 9. On the basis of these results, it is can be suggested that metformin should be coadministered with care along with H(2) receptor antagonists especially in case of ranitidine; although chances of adverse reactions are rare but decrease availability of metformin may result in delayed effect. On the other hand, increase in metformin concentration may result in hypoglycemic effects.

Cimetidine↗

[Can the survival of patients with recurrent disease after curative resection of colorectal cancer be prolonged by the administration of cimetidine?].

Administration of cimetidine after curative surgery can improve prognosis of patients with colorectal cancer. In this study, we analyzed whether cimetidine can influence the survival of patients with a recurrent disease after colorectal surgery. The subjects were 29 patients with recurrent disease: 14 patients were administered with cimetidine and 15 patients were not. In the cimetidine administered group, seven cases were recurrent in the liver, 5 cases in a local site and 1 case in the lymph node, whereas 7 cases were recurrent in the liver, 4 cases in a local site and 3 cases in the lung for the non-cimetidine administered group. There were no significant differences for both groups in terms of patient's survival after recurrence. Although it was not significant, the patient's survival after curative resection of recurrent disease for the cimetidine administered group was better than the non cimetidine administered group. Although the results did not show cimetidine could influence the overall survival of the patients after recurrence, it might be possible to improve the survival of the patients after resection of the recurrent disease.

Cimetidine↗